نتائج البحث

Administration of Nirmatrelvir-ritonavir for COVID-19, 13 January 2023

• Authors : World Health Organization

Subjects: COVID-19; SARS-CoV-2; nirmatrelvir and ritonavir drug combinationGeneva

تفاصيل العنوان

Safety and monitoring for patients receiving Nirmatrelvir-ritonavir for COVID-19, 19 July 2022

• Authors : World Health Organization

Subjects: COVID-19; SARS-CoV-2; SafetyGeneva

تفاصيل العنوان

Administration of Nirmatrelvir-ritonavir for COVID-19. 19 July 2022

• Authors : World Health Organization

Subjects: COVID-19; SARS-CoV-2; nirmatrelvir and ritonavir drug combinationGeneva

تفاصيل العنوان

Nirmatrelvir-ritonavir for COVID-19, 19 July 2022

• Authors : World Health Organization

Subjects: COVID-19; SARS-CoV-2; nirmatrelvir and ritonavir drug combinationGeneva

تفاصيل العنوان

NIRMATRELVIR (NIRMATRELVIRUM).

Subjects: WORLD Health Organization; HIGH performance liquid chromatography; ANTIVIRAL agents

• Source: WHO Drug Information. 2023, Vol. 37 Issue 3, p642-650. 9p.

تفاصيل العنوان

Ritonaviri compressi Ritonavir tablets.

Subjects: ANTIVIRAL agents; PHARMACEUTICAL chemistry; PHARMACOLOGY

• Source: WHO Drug Information. 2011, Vol. 25 Issue 4, p409-412. 4p. 1 Chart.

تفاصيل العنوان

RITONAVIR.

• Source: International Pharmacopoeia: Fourth Edition. 2006, Vol. 2, p837-840. 4p.

تفاصيل العنوان

Therapeutics and COVID-19: living guideline, 31 March 2021

• Authors : World Health Organization

Subjects: COVID-19; Betacoronavirus; Disease OutbreaksGeneva

تفاصيل العنوان

Ritonavirum (final).

• Source: WHO Drug Information. 2005, Vol. 19 Issue 1, p59-61. 3p.

تفاصيل العنوان

The International Pharmacopoeia: monographs for antiretrovirals.

• Source: WHO Drug Information. 2004, Vol. 18 Issue 4, p305-307. 3p.

تفاصيل العنوان